PART3: UNTREATED CLL

Clinical trials for PART3: UNTREATED CLL explained in plain language.

Never miss a new study

Get alerted when new PART3: UNTREATED CLL trials appear

Sign up with your email to follow new studies for PART3: UNTREATED CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug trial targets tough blood cancers in japan

Disease control Ongoing

This early-stage study is testing a drug called acalabrutinib in Japanese adults with advanced B-cell blood cancers, such as certain types of leukemia and lymphoma. The main goal is to check the drug's safety, how the body processes it, and see if it shows any signs of fighting t…

Matched conditions: PART3: UNTREATED CLL

Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

PART3: UNTREATED CLL

Get alerted when new PART3: UNTREATED CLL trials appear

New drug trial targets tough blood cancers in japan